Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinlu Biotechnology is a specialized biotechnology company headquartered in Jinan, China, focusing on the development and manufacture of in vitro diagnostic (IVD) solutions and animal health products. The company's core expertise lies in molecular diagnostics, particularly the development of high-sensitivity nucleic acid detection kits for a variety of human pathogens, including respiratory and gastrointestinal viruses. Beyond human diagnostics, Shandong Xinlu Biotechnology is a significant player in the veterinary sector, providing diagnostic reagents and vaccines for livestock and poultry. The company operates state-of-the-art R&D and manufacturing facilities that comply with international quality standards, including GMP. By leveraging advanced PCR and molecular biology platforms, the company serves hospitals, CDC centers, and veterinary clinics across China and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinlu Biotechnology.